Anat Ben-Shlomo

Cedars-Sinai Medical Center

Papers

2

Total Citations

21

H-Index

2

About

Dr. Anat Ben-Shlomo is a leading surgical oncologist whose research focuses on improving outcomes for patients with adrenocortical carcinoma (ACC), a rare and aggressive endocrine malignancy. Her work centers on refining surgical management strategies, particularly the role of lymphadenectomy and the impact of operative approach on achieving negative resection margins. In her highly cited 2021 study, Dr. Ben-Shlomo demonstrated the prognostic value of systematic lymph node dissection in ACC, providing critical evidence for standardized surgical protocols. Her 2022 follow-up research further established that high case volume and specific operative techniques are independently associated with R0 resections, directly influencing survival rates. With over 20 combined citations for these landmark papers, her contributions have shaped current guidelines for ACC surgery. Dr. Ben-Shlomo’s work bridges the gap between surgical practice and oncologic outcomes, offering actionable insights for surgeons treating this challenging disease. Her research is essential reading for clinicians and trainees seeking to optimize surgical care for rare adrenal tumors.

Research Focus

Key Achievements

2
H-Index
2
Papers
21
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Adrenocortical Carcinoma: The Value of Lymphadenectomy
11 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Cedars-Sinai Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago